Funding for this research was provided by:
Hamad Medical Corporation
Received: 6 December 2020
Accepted: 20 March 2021
First Online: 7 April 2021
: The patient provided signed consent for participation and publication of this article. The proposal was accepted by the international review board (IRB) at Hamad Medical Corporation (Protocol ID: MRC-04-20874).
: The patient signed written informed consent for publication of this article.
: P.M.H. reports personal fees from Janssen, Lundbeck, Otsuka, NewBridge Pharmaceuticals and Sunovion, outside the submitted work. The other authors report no conflicts of interest with respect to the research, authorship, and/or publication of this article.